ClinicalTrials.Veeva

Menu

A Study to Characterize Access to Specialty Care Received by American Indians/Alaska Natives (CATORI)

Genentech logo

Genentech

Status

Completed

Conditions

Specialist Referral: Neurology
Specialist Referral: Ophthalmology
Specialist Referral: Oncology

Treatments

Other: No Intervention

Study type

Observational

Funder types

Industry

Identifiers

NCT05624788
ML44072

Details and patient eligibility

About

This is an observational study to define current care pathways for American Indian or Alaska Native patients who require specialty care and potential feasibility of conducting clinical research within the existing framework. The study is designed with the flexibility to enroll patients with any indication requiring referral to one of the following specialists: neurologist, ophthalmologist, or oncologist. Eligible patients will have recently (≤6 months) been referred to a specialty care provider and not yet seen a specialist (in addition to meeting the other eligibility criteria). The PPD virtual site can enroll patients from anywhere across the United States.

The study will collect data to determine whether a patient was seen by a specialist, diagnosed with a specialized disease, patient characteristics potentially associated with being seen or not seen by a specialist, and the reasons/barriers why a patient was not seen by a specialist through a number of patient surveys.

Enrollment

84 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ability to read English at 8th grade proficiency or have a household member willing to assist in translation to complete patient surveys
  • Self-identification as American Indian or Alaska Native
  • Referred to a neurologist, ophthalmologist, or oncologist for the first time within 6 months of screening and has not been seen by the specialist. Exception: Patients referred to an oncologist who have had a first-time visit with an oncologist but have a pending follow-up visit or pending referral visit within 6 months of screening may be included in the study.
  • Personal landline or cell phone and/or access to internet
  • Willingness to complete all surveys in the study and participate for 12 months

Exclusion criteria

  • Currently under the care of a specialist (neurologist, ophthalmologist, or oncologist) to whom they are being referred to by the primary care provider (i.e., to be eligible, the specialty care physician should be new to the participant) at time of screening
  • Currently or planned to receive care that requires in participant visits for the indication requiring referral from the primary care provider (e.g., radiotherapy, chemotherapy for cancer diagnosis). Exception: Patients referred to an oncologist who have had a first-time visit with an oncologist but have a pending follow-up visit or pending referral visit may be included in the study.

Trial design

84 participants in 3 patient groups

Specialist Referral: Neurology
Treatment:
Other: No Intervention
Specialist Referral: Ophthalmology
Treatment:
Other: No Intervention
Specialist Referral: Oncology
Treatment:
Other: No Intervention

Trial contacts and locations

2

Loading...

Central trial contact

Reference Study ID Number: ML44072 https://forpatients.roche.com/

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems